+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anoro"

From
From
Anoro Ellipta - API Insight, 2022 - Product Thumbnail Image

Anoro Ellipta - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Anoro Ellipta- Drug Insight, 2019 - Product Thumbnail Image

Anoro Ellipta- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Anoro - Product Thumbnail Image

Anoro

  • Report
  • July 2018
  • 20 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Anoro is a brand of respiratory drugs used to treat chronic obstructive pulmonary disease (COPD). It is a combination of two drugs, umeclidinium and vilanterol, which work together to relax the airways and reduce inflammation. Anoro is taken as an inhaler and is used to reduce symptoms such as shortness of breath, wheezing, and coughing. It is also used to prevent flare-ups of COPD. Anoro is part of a larger market of respiratory drugs, which includes other brands such as Breo, Spiriva, and Symbicort. These drugs are used to treat a variety of respiratory conditions, including asthma, COPD, and bronchitis. They are available in both inhaler and pill form, and are often prescribed in combination with other medications. The companies in the Anoro market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, and Novartis. Show Less Read more